Cash

£59K

-85.9% vs 2023

Net assets

£63K

-20.2% vs 2023

Employees

9

+12.5% vs 2023

Profit before tax

-£16K

-222.4% vs 2023

Profile

Company number
09980630
Status
Active
Incorporation
2016-02-01
Last accounts made up
2024-09-30
Account category
FULL
Primary SIC
86900
Hubs
UK Healthcare

Profit before tax

3-year trend · vs UK Healthcare median

£0£10k£20k202220232024
INTERNATIONAL SOCIETY OF SUBSTANCE USE PREVENTION AND TREATMENT PROFESSIONALS

Accounts

3-year trend · latest 2024-09-30

Metric Trend 2022-09-302023-09-302024-09-30
Turnover
Operating profit
Profit before tax £16,943£12,984-£15,895
Net profit £14,289£11,386-£15,895
Cash £519,447£418,198£59,144
Total assets less current liabilities £67,463£78,849£62,954
Net assets
Equity £78,849£62,954
Average employees 889
Wages

Values shown as filed in iXBRL accounts. indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers

Audit & accounting basis

From AI-extracted PDF accounts

Accounting basis
FRS 102 §1A
Reporting scope
Standalone (parent only)
Abridged
Yes — abridged accounts (limited disclosure)
Auditor
HW Fisher Audit
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. The directors are confident that the company can continue as a going concern for a period of at least twelve months from the date of approval of these financial statements. The directors also have a reasonable expectation that the company has adequate resources to continue in operation and that future cash inflows are assured. This is due to an active grant agreement with the U.S. Department of State's Bureau of International Narcotics and Law Enforcement Affairs (INL), ISSUP's main funder. A strong relationship has been established due to six previous years of funding, and a new grant agreement has been approved to 30 September 2026. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.”

Subsidiaries

Significant events

Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers

People

6 active · 11 resigned

Name Role Appointed Born Nationality
TRAVIS-ROBERTS, Joanna Kathryn Secretary 2016-02-01
AGWOGIE, Martin Osayande Director 2020-10-13 Dec 1970 Nigerian
EVANS, Vivienne Marion Director 2016-02-17 Oct 1947 British
GORLERO, Carolina Ines Director 2025-02-10 Dec 1981 Argentine
HEAPS, Melody Mary Director 2016-02-01 Jul 1943 American
MIOVSKY, Michal, Professor Director 2020-02-13 Sep 1975 Czech
Show 11 resigned officers
Name Role Appointed Resigned
ABELLA JR, Clemente Director 2016-02-10 2018-12-01
FOXCROFT, David, Prof Director 2016-02-24 2019-03-12
GAKUNJU, Richard Mwangi, Dr Director 2016-02-10 2018-12-01
LE ROUX, Louina Director 2016-02-12 2018-12-03
LEE, Jeffrey Talbot Director 2016-02-01 2017-10-31
MARTELLI, Paulo Vicente Director 2016-02-10 2018-12-05
RIBALDO, Carlos Alberto Torres Director 2016-02-10 2019-01-14
SETIAWAN, Antonius Riva Director 2016-12-01 2018-06-15
SLOBODA, Zili, Dr Director 2016-02-10 2018-12-05
THAU, Susan Rosenberg Director 2016-02-10 2025-12-04
TRAVIS-ROBERTS, Joanna Kathryn Director 2016-02-01 2019-09-03

Ownership

Persons with significant control

No PSC data extracted yet.

Filing timeline

Last 20 of 57 total filings

Date Type Category Description
2026-01-15 CS01 confirmation-statement confirmation statement with no updates
2025-12-16 CH01 officers change person director company with change date
2025-12-08 TM01 officers termination director company with name termination date
2025-09-29 AA accounts accounts with accounts type full
2025-02-13 AP01 officers appoint person director company with name date
2025-01-29 CS01 confirmation-statement confirmation statement with no updates
2024-09-25 AA accounts accounts with accounts type full
2024-01-16 CS01 confirmation-statement confirmation statement with no updates
2023-06-23 AA accounts accounts with accounts type small
2023-01-16 CS01 confirmation-statement confirmation statement with no updates
2022-09-13 AA accounts accounts with accounts type small
2022-01-27 CS01 confirmation-statement confirmation statement with no updates
2021-09-25 AA accounts accounts with accounts type small
2021-01-26 CS01 confirmation-statement confirmation statement with no updates
2020-11-03 AA01 accounts change account reference date company previous shortened
2020-10-29 AA accounts accounts with accounts type small
2020-10-16 AP01 officers appoint person director company with name date
2020-10-06 AP01 officers appoint person director company with name date
2020-01-23 CS01 confirmation-statement confirmation statement with no updates
2019-10-10 AA accounts accounts with accounts type small

Credit score

Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage

Credit score requires retained earnings proxy, book equity — not present in the latest extracted accounts.

Activity Score

Composite activity score · components 0–100 · reference 2026-05-10

27.2

COLD

/ 100

  • Filings velocity 33
  • Capital events 0
  • Officer churn 25
  • Headcount trajectory 63
  • Accounts trajectory 30
  • 4 filing(s) in last 12 months
  • 0 appointed, 1 resigned (12mo)
  • Employees +12% YoY
  • Total Assets Less Current Liabilities -20% YoY

Official Companies House page